Cargando…

The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer

Chromosome region 3p12‐14 is an important tumour suppressor gene (TSG) locus for multiple cancers. ADAMTS9, a member of the metalloprotease large family, has been identified as a candidate 3p14.2 TSG inactivated by aberrant promoter CpG methylation in several carcinomas, but little known about its e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Bianfei, Feng, Yixiao, Zhang, Hongbin, Yu, Fang, Li, Qianqian, Tan, Cui, Xu, Hongying, Ying, Jianming, Li, Lili, Yang, Dejuan, Peng, Weiyan, Tang, Jun, Li, Shuman, Ren, Guosheng, Tao, Qian, Xiang, Tingxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783842/ https://www.ncbi.nlm.nih.gov/pubmed/29193730 http://dx.doi.org/10.1111/jcmm.13404

Ejemplares similares

KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer
por: Pei, Lijiao, et al.
Publicado: (2018)

Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β‐catenin signalling and GADD45G expression
por: Zhao, Lijuan, et al.
Publicado: (2016)

Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53
por: Petrovich, Miriana, et al.
Publicado: (2009)

The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling
por: Zhang, Chong, et al.
Publicado: (2018)

DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2016)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF‐κB signaling
por: Xu, Hongying, et al.
Publicado: (2017)

Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer
por: Xiao, Yun, et al.
Publicado: (2014)

Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim
por: Paschos, Kostas, et al.
Publicado: (2009)

19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer
por: Sun, Ran, et al.
Publicado: (2020)

Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer
por: Xiang, Shili, et al.
Publicado: (2017)

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
por: Tan, Yiqing, et al.
Publicado: (2021)

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
por: Ying, J, et al.
Publicado: (2009)

The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism
por: Feng, Yixiao, et al.
Publicado: (2018)

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
por: Bae, J M, et al.
Publicado: (2013)

Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer
por: Yin, Xuedong, et al.
Publicado: (2016)

Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)

Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation
por: Li, Xia, et al.
Publicado: (2018)

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer
por: Wang, Yan, et al.
Publicado: (2022)

Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer
por: Mu, Junhao, et al.
Publicado: (2017)

The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest
por: Zhang, Yan, et al.
Publicado: (2018)

TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
por: Fan, Jiangxia, et al.
Publicado: (2018)

Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)

Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)

Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
por: Serrano, Isabel, et al.
Publicado: (2013)

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
por: Dopeso, Higinio, et al.
Publicado: (2018)

CpGPAP: CpG island predictor analysis platform
por: Chuang, Li-Yeh, et al.
Publicado: (2012)

DNA methylation determines nucleosome occupancy in the 5′-CpG islands of tumor suppressor genes
por: Portela, A, et al.
Publicado: (2013)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012)

CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function
por: Jang, Hyun Sik, et al.
Publicado: (2017)

The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
por: Du, Zhenfang, et al.
Publicado: (2016)

ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021)

Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
por: Millward, M, et al.
Publicado: (2013)

Prediction of CpG-island function: CpG clustering vs. sliding-window methods
por: Hackenberg, Michael, et al.
Publicado: (2010)

CpG Methylation Altered the Stability and Structure of the i-Motifs Located in the CpG Islands
por: Oshikawa, Daiki, et al.
Publicado: (2022)

Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours
por: Dunn, J R, et al.
Publicado: (2006)

Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma
por: Cui, Xiaobin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pemoj26lvs5qbjktim4rgl8nno